This therapy involves evaluating the signs and symptoms of pulmonary hypertension, managing side effects, and caring for central venous catheters. The authors discuss the nursing management needed to optimize patients’ outcomes.

Patients with pulmonary arterial hypertension (PAH) are often admitted to the hospital electively for parenteral therapy or right-sided heart catheterization and urgently for worsening right ventricular failure, life-threatening illnesses such as pneumonia or sepsis, and a variety of other medical problems. Because of the novelty of intravenous (IV) tre-prostinil administration, in this review, we attempt to provide nurses with guidance and information about the overall requirements for safe administration of IV treprostinil. The information is based on our own experiences in administering this therapy to patients with PAH.

PAH is a progressive disease characterized by an elevation in pulmonary artery pressure and pulmonary vascular resistance potentially leading to...

You do not currently have access to this content.